Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-05

FDA Approved: RAMELTEON — Supplemental Application (TruPharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for ramelteon submitted by TruPharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

SUPPL AP for RAMELTEON (RAMELTEON)